Edition:
United States

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

324.90INR
6:23am EDT
Change (% chg)

Rs0.35 (+0.11%)
Prev Close
Rs324.55
Open
Rs325.00
Day's High
Rs335.00
Day's Low
Rs320.00
Volume
85,913
Avg. Vol
95,326
52-wk High
Rs430.10
52-wk Low
Rs159.80

CLAI.BO

Chart for CLAI.BO

About

Claris Lifesciences Limited is a holding company. The Company is engaged in manufacturing of drugs and pharmaceutical products. The Company's geographical segments are India and Outside India. The Company's subsidiary, Claris Injectables Limited, is engaged in specialty Injectables business. The Company manufactures and markets... (more)

Overall

Beta: 1.04
Market Cap(Mil.): Rs17,709.97
Shares Outstanding(Mil.): 54.57
Dividend: 2.00
Yield (%): 0.62

Financials

  CLAI.BO Industry Sector
P/E (TTM): -- 14.29 17.36
EPS (TTM): -0.45 -- --
ROI: -- -7.57 -5.72
ROE: -- -7.17 -5.10

BRIEF-Claris Lifesciences approves sale of shares of Otsuka Pharmaceutical India for $20 mln

* Says approved sale of shares of Otsuka Pharmaceutical India to Otsuka Pharmaceutical Factory for $20 million Source text for Eikon: Further company coverage:

May 08 2017

BRIEF-Claris Lifesciences gets members' nod for sale, transfer of injectable business

* Gets members' nod for sale and transfer of injectable business of co by way of sale of subsidiary companies Source text: http://bit.ly/2kD0uPT Further company coverage:

Feb 20 2017

BRIEF-Claris Lifesciences posts consol Dec qtr profit

* Consol dec quarter total income from operations 86.3 million rupees

Feb 14 2017

BRIEF-Claris Lifesciences seeks members' nod for sale/transfer of its injectables business

* Seeks members' nod for sale, transfer of 'injectables business' carried on by the company in India and overseas for $625 million Source text: http://bit.ly/2jF4Sd2 Further company coverage:

Jan 17 2017

More From Around the Web

Earnings vs. Estimates